CompletedNot Applicable

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Italy90 participantsStarted 2020-05-01

Plain-language summary

The aim of this study is to verify if patients admitted to hospital in a medical division and in the intensive care unit for a COVID-19 infection are at higher risk of developing a VTE complication and if they actually present an increased hypercoagulable state.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged \>= 18 years * needing admission to a medical hospital division or to an ICU * with a confirmed infection for COVID-19 Exclusion Criteria: * aged \< 18 years

What they're measuring

the cumulative proportion of any distal or proximal deep venous thrombosis or of symptomatic pulmonary embolism

Timeframe: 28 days

Trial details

NCT IDNCT04359212

SponsorQuovadis Associazione

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-06-30

View on ClinicalTrials.gov More COVID-19 Disease trials